- Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and womenSherri Ann M Burnett
Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Bone Miner Res 21:1187-96. 2006..Dietary phosphate is a key regulator of circulating FGF-23; choice of assay is critical when studying FGF-23 physiology...
- Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic menJoel S Finkelstein
Endocrine Unit, Bulfinch 327, Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
J Clin Endocrinol Metab 91:2882-7. 2006..We have previously demonstrated that alendronate reduces the ability of teriparatide to increase bone mineral density (BMD) in osteoporotic men. The underlying basis for this observation is poorly understood...